Has Stanley Mathew, MD received payments from drug or device companies?

Yes. Drug and device makers reported $258 in general payments to Stanley Mathew, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stanley Mathew, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stanley Mathew, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stanley Mathew, MD

Physical Medicine & Rehabilitation · Cedar Rapids, IANPI 1003053653

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by AbbVie at 36.5% of the total. 2025 is the largest year on record at $91, 2.4 times the $38 reported in 2019.

$258in general payments, 2019–2025

Across 14 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$94
Pfizer$50
Vertex$50
Supernus Pharmaceuticals, Inc.$46
MDD US Operations, LLC$18

What the payments were for

Food & beverage$258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	5	$94
Pfizer	3	$50
Vertex	3	$50
Supernus Pharmaceuticals, Inc.	2	$46
MDD US Operations, LLC	1	$18

How this compares

$258 in reported general payments places this provider in the 65th percentile of 58 physical medicine & rehabilitation providers in Iowa.

See all physical medicine & rehabilitation providers in Iowa →

Medicare billing

Part B allowed, 2024

$1,172,207

Medicare patients

1,733

Services billed

12,860

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	1,193	$363,753
XareltoRivaroxaban	284	$85,839
Abiraterone Acetate	12	$82,509
JardianceEmpagliflozin	255	$81,908
Invega SustennaPaliperidone Palmitate	21	$77,410
TrulicityDulaglutide	123	$70,022
MyrbetriqMirabegron	216	$48,790
BriviactBrivaracetam	56	$29,514
Gabapentin	1,049	$26,871
Potassium Chloride	928	$25,827
Dimethyl Fumarate	20	$25,615
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	41	$25,336
Atorvastatin Calcium	1,470	$25,038
Nurtec OdtRimegepant Sulfate	17	$24,771
Breo ElliptaFluticasone/Vilanterol	54	$22,931

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis, Nurtec Odt	$50	$388,5231,210 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 58 physical medicine & rehabilitation providers in Iowa.

Other physical medicine & rehabilitation in Cedar Rapids

Nicholas ApplebyCedar Rapids$49K
Sunny KimCedar Rapids$3K
Roman MagidCedar Rapids$296
Justin GilbertCedar Rapids$194
Devin SmithCedar Rapids$140
Craig DoveCedar Rapids$51
Neil SegalIowa City$2.2M
Ryan KruseIowa City$8K
Daniel GoldishNorth Liberty$6K
Ai Huong PhuClive$6K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →